X

Please update your browser.

For the best experience, we recommend that you use the latest version of Chrome, Internet Explorer, or Firefox.

Tom invests in venture and growth-oriented companies with a focus on the healthcare technology space. He led Adams Street’s investments in Lyra Health, VillageMD, BioAgilytix, SymphonyRM, Therapy Brands, Grand Rounds Health, Solera Health, and Healthfinch.  He is also on the Board of MyHealthTeams.

Prior to joining the firm, he worked at Summit Partners as a Vice President where he sourced, evaluated, and executed investments in the technology and healthcare sectors.

Previously, Tom worked at The Edgewater Funds, where he assisted in investment activities including new deal generation, diligence, and portfolio company operations. His background also includes experience with JP Morgan Chase, where he was responsible for business development and credit analysis within the commercial banking segment.

Tom is a member of Adams Street’s Growth Equity Investment Committee and Diversity, Equity & Inclusion Committee.

CURRENT INVESTMENTS

BioAgilytix, Grand Rounds Health, Lyra Health, Nomad Health, Redox Engine, Reify Health, Solera Health, SymphonyRM, and VillageMD

PAST INVESTMENTS

Carecloud (acquired by MTBC), Healthfinch (acquired by Health Catalyst), Maxwell Health (acquired by Sun Life), PeopleAdmin (acquired by Vista Equity Partners), Solutionreach, and Therapy Brands (acquired by KKR)

Learn more about Adams Street Partners